SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Supernus Pharmaceuticals Reports Third-Quarter 2026 Revenue of $226.77 Million

Supernus Pharmaceuticals reported third-quarter 2026 revenue of $226.77 million, up 18% from a year earlier, net income of $20.91 million versus a $45.12 million loss, and diluted EPS of $0.35 versus a loss of $0.8 per share.

SUPN
SquawkNews Desk

Related stories

Coinbase Q3 Net Income Jumps 66% to $719 Million Coinbase reported third-quarter net income of $719 million. Its prediction markets and derivatives businesses helped offset weaker spot trading activity, analysts said. M impact | EARNINGS | Oct 30, 2026, 09:01 AM UTC FTSE 100 Rises Led by Astra & BP The FTSE 100 rose 0.5% on Friday, outperforming global markets amid a tech-led selloff, as strong earnings from heavyweight stocks AstraZeneca and BP supported the index. AstraZene H impact | EARNINGS | Oct 30, 2026, 08:56 AM UTC FTSE MIB Decline Milan’s FTSE MIB fell over 1% to around 49,500 on Friday, snapping a five-day winning streak as weakness in technology stocks weighed on the index. Concerns over returns from massi L impact | EARNINGS | Oct 30, 2026, 08:48 AM UTC European Stocks Fall as Tech Weighs European stocks traded in negative territory on Friday, with the STOXX 50 falling 0.7% and the STOXX 600 slipping 0.2%. The European technology sector joined a global sell-off foll H impact | EARNINGS | Oct 30, 2026, 08:44 AM UTC Amazon’s Third-Quarter Profit Falls, Missing Wall Street Expectations Amazon reported lower profit in the third quarter, missing Wall Street expectations. M impact | EARNINGS | Oct 30, 2026, 08:44 AM UTC Puma Narrows 2026 Operating Loss Guidance as Quarterly Sales Top Market View M impact | EARNINGS | Oct 30, 2026, 08:38 AM UTC